Instytut Fizjoterapii I Biotechnologii P.S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Recreational Goods Rental | Scientific Research and Development Services | Tour Operators | All Other Miscellaneous Schools and Instruction | Offices of Physicians | All Other Miscellaneous Ambulatory Health Care Services | Other Personal Care Services | Administration of Economic Programs

Full name: Instytut Fizjoterapii I Biotechnologii P.S.A.

Profile Updated: April 23, 2025

Instytut Fizjoterapii I Biotechnologii P.S.A. is an enterprise based in Poland. Its main office is in Rzeszow. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was first established on September 24, 2024. The company’s latest financial report indicates a net sales revenue drop of 29.51% in 2025. Its’ total assets recorded a growth of 39.91%. The enterprise’s net profit margin increased by 4.08% in 2025.

Headquarters
Ul. Pl. Jana Kilinskiego 2
Rzeszow; Podkarpackie; Postal Code: 35-005

Contact Details: Purchase the Instytut Fizjoterapii I Biotechnologii P.S.A. report to view the information.

Basic Information

Registered Capital:

Purchase the Instytut Fizjoterapii I Biotechnologii P.S.A. report to view the information.

Financial Auditors:

Purchase the Instytut Fizjoterapii I Biotechnologii P.S.A. report to view the information.

Incorporation Date:

September 24, 2024

Key Executives

Purchase this report to view the information.

Managing Director

Company Performance

Financial values in the chart are available after Instytut Fizjoterapii I Biotechnologii P.S.A. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-29.51%▼

Total Operating Revenue

-32.36%▼

Operating Profit

-17.5%▼

EBITDA

121.04%▲

Net Profit/Loss for the Period

11.4%▲

Total Assets

39.91%▲

Total Equity

5.27%▲

Operating Profit Margin

1.62%▲

Net Profit Margin

4.08%▲

Return on Equity (ROE)

0.23%▲

Quick Ratio

-9.23%▼

Similar companies